Substance Use

Latest News

FDA Approves First OTC Naloxone Nasal Spray for Treatment of Opioid Overdoses| Image Credit: ©Hanson - ©Hason - stock.adobe.com
FDA Approves First OTC Naloxone Nasal Spray for Treatment of Opioid Overdoses

March 29th 2023

Narcan naloxone hydrochloride nasal spray 4 mg is expected to be available in-store and online by the late summer.

Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Daily Dose: E-cigarette Screening in Primary Care

March 14th 2023

young teenager vaping e-cigarette
Screening Rates for E-cigarette Use in Primary Care Lower than for Other Substances, According to New Research

March 13th 2023

Face of young man vaping
Depression, Anxiety More Common Among Teenagers, Young Adults Who Vape Marijuana and Nicotine

March 7th 2023

Program Could Help Integrate Treatment for Alcoholism into Primary Care
Program Could Help Integrate Treatment for Alcoholism into Primary Care

February 28th 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.